Journal
PHARMACEUTICS
Volume 14, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics14030645
Keywords
cancer imaging; dual probes; fluorescence; positron emission tomography
Categories
Funding
- Dianne and Irving Kipnes Foundation
- Natural Sciences and Engineering Research Council of Canada (NSERC)
Ask authors/readers for more resources
Combining PET and fluorescence imaging techniques can optimize the treatment outcomes for tumor patients. This review discusses the recent research on integrating these two imaging capabilities into one.
Simple Summary Being able to detect and image tumors is extremely important for proper diagnosis and treatment. The most sensitive technique, positron emission tomography (PET), is widely applied for such a purpose. Additionally, fluorescence imaging can be used to visually see the margins between healthy and cancerous tissue during surgery. These two techniques can be combined to optimize patient outcomes by ensuring maximum tumor removal. This review will discuss the work that has been done recently to combine these two imaging capabilities into one imaging agent. Dual probes that possess positron emission tomography (PET) and fluorescence imaging (FI) capabilities are precision medicine tools that can be used to improve patient care and outcomes. Detecting tumor lesions using PET, an extremely sensitive technique, coupled with fluorescence-guided surgical resection of said tumor lesions can maximize the removal of cancerous tissue. The development of novel molecular probes is important for targeting different biomarkers as every individual case of cancer has different characteristics. This short review will discuss some aspects of dual PET/FI probes and explore the recently reported examples.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available